Skip to main content

Gengos Andrew

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Gengos Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TERN Terns Pharmaceuticals, Inc.

Chief Financial Officer2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 30, 2025 (view filing)Jun 273 daysGengos AndrewChief Financial OfficerPPurchase+10.0K$3.93+$39.3K+66.7%25.0K after2 lots
Jun 16, 2025 (view filing)Jun 13-163 daysGengos AndrewChief Financial OfficerPPurchase+15.0K$3.81+$57.1KNew position15.0K after3 lots

LONA LeonaBio, Inc.

CFO and Chief Business Officer4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 5, 2024 (view filing)Sep 5Same dayGengos AndrewCFO and Chief Business OfficerSSale−1.27K$0.57−$725.04−1.3%97.5K after
Feb 16, 2024 (view filing)Jan 542 daysGengos AndrewCFO AND CHIEF BUSINESS OFFICERSSale−1.21K$2.91−$3.52K−1.4%83.8K afterAmended
Jun 9, 2023 (view filing)Jun 72 daysGengos AndrewSee BelowPPurchase+15.0K$3.43+$51.5K+23.1%80.0K after3 lots
Jun 6, 2023 (view filing)Jun 2-54 daysGengos AndrewSee BelowPPurchase+65.0K$2.95+$191.6KNew position65.0K after7 lots